4//SEC Filing
aTYR PHARMA INC 4
Accession 0001209191-16-142490
$ATYRCIK 0001339970operating
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 4:53 PM ET
Size
5.5 KB
Accession
0001209191-16-142490
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
King David John
See Remarks
Transactions
- Award
Employee Stock Option (right to buy)
2016-09-21+145,000→ 145,000 totalExercise: $3.29Exp: 2026-09-21→ Common Stock (145,000 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to this option shall vest and become exercisable on September 21, 2017, and the remainder shall thereafter vest in 36 equal monthly installments, such that this option is fully exercisable on September 21, 2020. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001339970
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 4:53 PM ET
- Size
- 5.5 KB